Etravirine (ETR) is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) designed for binding to HIV reverse transcriptase in spite of most of the mutations which normally confer resistance to the other drugs of the same class. Evidences from clinical trials and post-marketing drug use provide guidance for the use of the drug in NNRTI-experienced patients. However, despite the raised genetic barrier, progressive loss of ETR susceptibility is seen as resistance mutations accumulate and a certain degree of cross-resistance with first-generation NNRTI occurs however. Moreover, most of the experiences in using ETR come from the setting of co-administration with darunavir/ritonavir, whilst little is known about its use with other companions. A full knowledge of all available evidences on the drug is therefore needed, in order to optimize the use of ETR in clinical practice.

Lapadula, G., Soria, A., & Gori, A. (2009). Pharmacotherapy of HIV: Focus on Etravirine. CLINICAL MEDICINE. THERAPEUTICS, 1, CMT.S2612 [10.4137/CMT.S2612].

Pharmacotherapy of HIV: Focus on Etravirine

Lapadula, Giuseppe
;
Soria, Alessandro;Gori, Andrea
2009

Abstract

Etravirine (ETR) is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) designed for binding to HIV reverse transcriptase in spite of most of the mutations which normally confer resistance to the other drugs of the same class. Evidences from clinical trials and post-marketing drug use provide guidance for the use of the drug in NNRTI-experienced patients. However, despite the raised genetic barrier, progressive loss of ETR susceptibility is seen as resistance mutations accumulate and a certain degree of cross-resistance with first-generation NNRTI occurs however. Moreover, most of the experiences in using ETR come from the setting of co-administration with darunavir/ritonavir, whilst little is known about its use with other companions. A full knowledge of all available evidences on the drug is therefore needed, in order to optimize the use of ETR in clinical practice.
Articolo in rivista - Review Essay
Scientifica
Etravirine, non-nucleoside reverse transcriptase inihibitors, antiretroviral therapy, HIV, AIDS, review
English
Lapadula, G., Soria, A., & Gori, A. (2009). Pharmacotherapy of HIV: Focus on Etravirine. CLINICAL MEDICINE. THERAPEUTICS, 1, CMT.S2612 [10.4137/CMT.S2612].
Lapadula, G; Soria, A; Gori, A
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/326148
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact